Lin Y - Search Results

1

Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor.

Lin Y, Yu B, Sun H, Zhang H, Hu Z, Zhang Y, Wu Z, Sun S, Zhao X, Yu H, Wu X, Li Y, Wang J, Wang H. Lin Y, et al. J Cancer Res Clin Oncol. 2023 Sep;149(11):8663-8671. doi: 10.1007/s00432-023-04806-y. Epub 2023 Apr 28. J Cancer Res Clin Oncol. 2023. PMID: 37115272 Free PMC article.

2

Direct Comparison Between the Addition of Pembrolizumab or Bevacizumab for Chemotherapy-Based First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer Lacking Driver Mutations.

Liao J, Liu C, Long Q, Wu X, Wang H, Yu H, Sun S, Zhang Y, Lin Y, Zhao X, Wang J. Liao J, et al. Among authors: lin y. Front Oncol. 2021 Sep 29;11:752545. doi: 10.3389/fonc.2021.752545. eCollection 2021. Front Oncol. 2021. PMID: 34660317 Free PMC article.

3

Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.

Zhang Y, Liao JT, Lin Y, Liu C, Wu ZH, Yu B, Sun S, Yu H, Hui XH, Wu XH, Zhao XM, Wang HJ, Zheng Q, Li Y, Hu ZH, Wang JL. Zhang Y, et al. Among authors: lin y. J Dig Dis. 2023 Aug-Sep;24(8-9):472-479. doi: 10.1111/1751-2980.13219. Epub 2023 Sep 16. J Dig Dis. 2023. PMID: 37596865

4

PD-L1 mRNA derived from tumor-educated platelets as a potential immunotherapy biomarker in non-small cell lung cancer.

Hu Z, Wang N, Zhang Y, Zhang D, Sun S, Yu H, Lin Y, Zhao X, Wang H, Wu X, Ichiki Y, Watanabe S, Gong Z, Chang J, Wang J. Hu Z, et al. Among authors: lin y. Transl Lung Cancer Res. 2024 Feb 29;13(2):345-354. doi: 10.21037/tlcr-24-29. Epub 2024 Feb 28. Transl Lung Cancer Res. 2024. PMID: 38496687 Free PMC article.

5

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.

Tran HT, Liu Y, Zurita AJ, Lin Y, Baker-Neblett KL, Martin AM, Figlin RA, Hutson TE, Sternberg CN, Amado RG, Pandite LN, Heymach JV. Tran HT, et al. Among authors: lin y. Lancet Oncol. 2012 Aug;13(8):827-37. doi: 10.1016/S1470-2045(12)70241-3. Epub 2012 Jul 2. Lancet Oncol. 2012. PMID: 22759480

6

The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.

Choueiri TK, Fay AP, Gagnon R, Lin Y, Bahamon B, Brown V, Rosenberg JE, Hutson TE, Baker-Neblett KL, Carpenter C, Liu Y, Pandite L, Signoretti S. Choueiri TK, et al. Among authors: lin y. Clin Cancer Res. 2013 Sep 15;19(18):5218-26. doi: 10.1158/1078-0432.CCR-13-0491. Epub 2013 Jul 23. Clin Cancer Res. 2013. PMID: 23881929 Free PMC article. Clinical Trial.

7

Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma.

Suttle AB, Ball HA, Molimard M, Hutson TE, Carpenter C, Rajagopalan D, Lin Y, Swann S, Amado R, Pandite L. Suttle AB, et al. Among authors: lin y. Br J Cancer. 2014 Nov 11;111(10):1909-16. doi: 10.1038/bjc.2014.503. Epub 2014 Oct 28. Br J Cancer. 2014. PMID: 25349968 Free PMC article.

8

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma.

Zhu Y, Pu Z, Li Z, Lin Y, Li N, Peng F. Zhu Y, et al. Among authors: lin y. Front Oncol. 2021 Jul 28;11:700528. doi: 10.3389/fonc.2021.700528. eCollection 2021. Front Oncol. 2021. PMID: 34395271 Free PMC article.

9

Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in China.

Li C, Zhuo L, Kang Y, Liu P, Huang W, Li Q, Ma K, Huang S, Lin X, Zhuang W, Wang H, Chen D, Wang H, He Q, Gao Z, Niu X, Jing Y, Yan L, Gao B, Wang D, Lin S, Wu S, Lin Y, Kang D, Lin F. Li C, et al. Among authors: lin y. Stroke Vasc Neurol. 2024 May 15:svn-2023-003004. doi: 10.1136/svn-2023-003004. Online ahead of print. Stroke Vasc Neurol. 2024. PMID: 38749536

10

Innovative technologies for the fabrication of 3D/4D smart hydrogels and its biomedical applications - A comprehensive review.

Shashikumar U, Saraswat A, Deshmukh K, Hussain CM, Chandra P, Tsai PC, Huang PC, Chen YH, Ke LY, Lin YC, Chawla S, Ponnusamy VK. Shashikumar U, et al. Among authors: lin yc. Adv Colloid Interface Sci. 2024 May 7;328:103163. doi: 10.1016/j.cis.2024.103163. Online ahead of print. Adv Colloid Interface Sci. 2024. PMID: 38749384 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49,103 results

Search Page